Clinical Data Management Systems: IT Infrastructure Guide

Posted: March 31, 2026 to Technology.

Tags: AI, Compliance, HIPAA, Data Breach, Cybersecurity

Clinical Data Management Systems: IT Infrastructure Guide for Research Organizations

A clinical data management system (CDMS) is the central technology platform that research organizations use to collect, validate, store, and manage data generated during clinical trials. These systems handle everything from patient enrollment records and adverse event reports to lab results and electronic case report forms. The IT infrastructure behind a CDMS directly determines whether a trial produces reliable, regulatory-compliant data or suffers from integrity failures that delay drug approvals, trigger FDA warning letters, or invalidate years of research.

For IT leaders at pharmaceutical companies, contract research organizations (CROs), academic medical centers, and biotech firms, supporting a clinical data management system is fundamentally different from supporting standard enterprise applications. The regulatory requirements are stricter, the data integrity standards are higher, and the consequences of system failures are measured in patient safety risks and millions of dollars in delayed timelines. Organizations that invest in clinical trial IT infrastructure from the beginning avoid the costly remediation that follows an FDA audit finding.

This guide covers the IT infrastructure requirements for deploying and maintaining clinical data management systems, including platform comparisons, electronic data capture (EDC) system specifications, 21 CFR Part 11 compliance, data integrity frameworks, integration requirements, validation protocols, and security architecture. Whether you are evaluating your first CDMS or migrating from a legacy platform, the infrastructure decisions you make today will affect every trial you run for the next decade.

What Is a Clinical Data Management System and Why Infrastructure Matters

A clinical data management system serves as the authoritative repository for all data collected during a clinical trial. It replaces paper-based case report forms with electronic data capture, automates edit checks and query management, maintains a complete audit trail of every data change, and produces the datasets that regulatory agencies review during the drug approval process. Modern CDMS platforms integrate with randomization systems, laboratory information management systems (LIMS), imaging platforms, and safety databases to create a unified data ecosystem for each trial.

The infrastructure supporting a CDMS must satisfy requirements that go far beyond typical enterprise IT. Every database transaction must be captured in an immutable audit trail. Every electronic signature must comply with FDA regulations. Every backup must be validated to confirm recoverability. Every access event must be logged and attributable to a specific individual. These are not best practices or recommendations; they are regulatory requirements that the FDA, EMA, and other health authorities enforce through inspections and audits.

When infrastructure fails in a clinical trial context, the consequences cascade. A database outage during a multi-site trial means research coordinators at dozens of hospitals cannot enter patient data, creating backlogs that introduce transcription errors. A failed backup that goes undetected means data loss could affect the statistical validity of trial results. A misconfigured access control that allows unauthorized users to modify records creates an audit trail gap that regulators will flag. IT infrastructure is not a support function for clinical data management; it is a foundational component of data quality.

Major CDMS Platforms Compared: Server Requirements and Architecture

Selecting a clinical data management system involves evaluating not just the application features but the infrastructure each platform demands. The five platforms most widely deployed across the pharmaceutical and research industries each have distinct architecture requirements that IT teams must plan for.

Medidata Rave

Medidata Rave is the market leader in cloud-based EDC and clinical data management, used by the majority of the top 25 pharmaceutical companies. As a SaaS platform hosted on Medidata's infrastructure (now part of Dassault Systemes), Rave eliminates on-premise server management but shifts the infrastructure burden to network connectivity, endpoint management, and integration architecture. IT teams must provision reliable, low-latency internet connections at every clinical site, configure firewall rules to allow HTTPS traffic to Medidata's endpoints, manage single sign-on (SSO) integration via SAML 2.0 or similar protocols, and maintain validated client workstations. Rave's API-driven architecture supports integration with external systems but requires middleware or integration platforms to handle data transformation and routing. Organizations typically need a dedicated integration server or ESB (enterprise service bus) to manage Rave's data feeds.

Oracle Clinical and Oracle Health Sciences

Oracle Clinical remains widely deployed in large pharmaceutical companies that invested in on-premise infrastructure during the early 2000s. It runs on Oracle Database (minimum 19c for current supported versions) and Oracle WebLogic Server, requiring substantial server resources: minimum 32 GB RAM and 8 CPU cores for the application tier, with the database tier sized according to trial volume (64 GB RAM and 16+ cores for organizations running multiple concurrent trials). Oracle Clinical requires dedicated database administrators familiar with Oracle RAC (Real Application Clusters) for high availability, Oracle Data Guard for disaster recovery, and Oracle Advanced Security for encryption. The total infrastructure footprint for an Oracle Clinical deployment, including development, validation, and production environments, typically spans 12-15 servers. Many organizations are migrating to Oracle's cloud-based InForm platform, which reduces on-premise requirements but requires the same network and integration infrastructure as other cloud CDMS platforms.

Veeva Vault CDMS

Veeva Vault CDMS is a newer entrant built on Veeva's multi-tenant cloud platform, gaining rapid adoption due to its unified approach that combines EDC, coding, data cleaning, and analytics in a single system. As a cloud-native platform, Vault CDMS requires no on-premise application servers, but IT teams must plan for network architecture that supports consistent sub-200ms latency to Veeva's data centers, browser compatibility management (Vault requires specific Chrome or Edge versions), integration with Veeva's other Vault applications (eTMF, CTMS, RIM) which many sponsors already use, and data extraction pipelines for biostatistics teams that work with SAS or R. Veeva provides validated cloud infrastructure with SOC 2 Type II certification and supports 21 CFR Part 11 compliance through built-in audit trails and electronic signatures.

OpenClinica

OpenClinica is an open-source EDC platform widely used by academic medical centers, government-funded research institutions, and smaller CROs. The open-source edition requires on-premise deployment on Linux servers (RHEL, CentOS, or Ubuntu LTS) running Apache Tomcat and PostgreSQL. Minimum server specifications for a small deployment (under 10 concurrent trials) are 16 GB RAM, 4 CPU cores, and 500 GB storage, though production deployments supporting multiple studies should plan for 32 GB RAM and 8 cores. OpenClinica Enterprise, the commercial version, adds features required for regulated trials (electronic signatures, enhanced audit trails) and is available as both on-premise and cloud-hosted options. IT teams choosing OpenClinica take on responsibility for server hardening, database administration, backup configuration, and system updates, making it a good fit for organizations with strong internal IT capabilities but a poor choice for those without dedicated technical staff.

REDCap

REDCap (Research Electronic Data Capture) is a web-based platform developed at Vanderbilt University and distributed free to member institutions through a consortium model. REDCap runs on PHP and MySQL/MariaDB, deployable on a single Linux or Windows server with modest requirements: 8 GB RAM, 4 CPU cores, and 200 GB storage for small to medium deployments. REDCap is widely used for investigator-initiated trials, registries, and surveys, but it lacks some features required for regulated Phase II-IV trials, such as full 21 CFR Part 11 compliant electronic signatures in the base installation. IT teams should note that REDCap's simplicity is both its strength and limitation: it is straightforward to deploy and maintain but may require significant customization and additional validation effort to meet the infrastructure requirements of a full clinical data management system for regulated submissions.

EDC System Requirements: Infrastructure for Multi-Site Clinical Trials

Electronic data capture systems, whether standalone or integrated within a broader CDMS, impose specific infrastructure requirements that differ from standard web applications. A multi-site clinical trial may involve 50 to 500 research sites across multiple countries, each needing reliable access to the EDC system for data entry, query resolution, and monitoring activities.

Server Sizing and Performance

EDC system performance must accommodate peak usage patterns unique to clinical trials. Site initiation visits, database lock activities, and data cleaning pushes create usage spikes where hundreds of concurrent users may access the system simultaneously. For on-premise deployments, plan for 2x the baseline concurrent user capacity to handle peak periods without degradation. Database servers should be sized with sufficient I/O throughput to handle complex edit check execution in real time, as data validation rules fire with every form save and can involve cross-form and cross-visit logic spanning thousands of records. Storage must account for the audit trail, which in a large trial can exceed the size of the clinical data itself because every field-level change generates a timestamped record.

Network Connectivity for Global Trials

Multi-site trials require network architecture that accounts for diverse connectivity conditions. Sites in major academic medical centers typically have enterprise-grade internet, but trials also enroll patients at community clinics, physician offices, and international sites where bandwidth may be limited or unreliable. IT infrastructure must support content delivery network (CDN) integration for cloud-hosted EDC platforms to minimize latency for geographically distributed sites, WAN optimization for on-premise deployments accessed over VPN connections, and quality of service (QoS) policies that prioritize EDC traffic on shared clinical site networks. Plan for minimum 5 Mbps dedicated bandwidth per site, with 10+ Mbps recommended for sites running multiple concurrent trials. Organizations managing complex trial networks benefit from the kind of managed IT services that provide proactive monitoring and rapid issue resolution across distributed environments.

Mobile Data Capture and Offline Capability

Modern clinical trials increasingly rely on mobile devices for direct data capture by patients (ePRO/eCOA), site staff using tablets during patient visits, and field monitors conducting source data verification. The IT infrastructure must support mobile device management (MDM) for provisioned trial devices, secure containerization for BYOD scenarios, certificate-based authentication for mobile clients, and offline data synchronization with conflict resolution. Offline capability is particularly critical for trials conducted in rural areas, developing countries, or clinical settings where WiFi is prohibited (such as certain imaging suites). The EDC system must queue data locally on the device, encrypt it at rest, and synchronize it to the central database when connectivity is restored, with full audit trail entries documenting the offline capture and synchronization timestamps.

21 CFR Part 11 Compliance: IT Implementation Requirements

FDA's 21 CFR Part 11 regulation establishes the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. For clinical data management systems, Part 11 compliance is not optional. Every IT infrastructure component that touches electronic records must be configured and validated to meet these requirements.

Electronic Signatures

Part 11 requires that electronic signatures be unique to one individual, not reused or reassigned, and composed of at least two distinct identification components (such as a user ID and password). For signing actions that are the legal equivalent of a handwritten signature, the system must require the signer to re-enter their credentials at the time of signing. IT infrastructure must support secure credential storage with one-way hashing (bcrypt or Argon2), account lockout policies after failed authentication attempts, session timeout controls that require re-authentication after periods of inactivity, and multi-factor authentication for high-risk actions. The authentication infrastructure must also maintain records that link each electronic signature to the signed record, the meaning of the signature (e.g., "reviewed," "approved," "verified"), and the date and time of signing.

Audit Trails

Part 11 mandates computer-generated, time-stamped audit trails that independently record the date and time of operator entries and actions that create, modify, or delete electronic records. The audit trail must capture who made the change, what was changed (previous value and new value), when the change was made, and why (a reason for change). IT infrastructure requirements for audit trail compliance include database-level audit logging that cannot be disabled or modified by application users, time synchronization across all servers using NTP with a reliable time source, sufficient storage capacity for audit trail data that grows continuously throughout a trial's lifecycle (often 5-10 years), and backup procedures that include audit trail data with the same recovery assurance as the clinical data itself. The audit trail must be immutable. Database administrators should not have the ability to modify audit trail records, which requires careful privilege separation in the database security model.

Access Controls

Part 11 requires that access to electronic records be limited to authorized individuals and that the system use operational checks to enforce permitted sequencing of steps and events. IT teams must implement role-based access control (RBAC) that maps to clinical trial roles (investigator, coordinator, monitor, data manager, medical coder), with principle of least privilege applied so users can only access data and functions necessary for their role. Directory services integration (Active Directory or LDAP) centralizes identity management, but the CDMS must maintain its own authorization layer because clinical trial role assignments are study-specific. Access reviews must be conducted periodically and documented, and terminated user accounts must be disabled promptly. Network-level access controls, including firewall rules, VPN requirements, and IP allowlisting, add defense-in-depth to application-level security.

Data Integrity: How IT Infrastructure Supports ALCOA+ Principles

Data integrity is the foundational requirement that underpins every clinical trial. The FDA, EMA, MHRA, and WHO all reference the ALCOA+ framework as the standard for data integrity in regulated environments. ALCOA+ stands for Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available. Each principle has specific IT infrastructure implications.

Attributable: Every data entry and modification must be traceable to the individual who performed it. IT infrastructure supports attributability through unique user accounts (no shared logins), authentication mechanisms that verify identity before granting access, and audit trails that link every transaction to a specific user ID. Shared accounts, even for system administration, violate this principle and create findings during regulatory inspections.

Legible: Data must be readable and permanently recorded. Infrastructure supports legibility through proper character encoding (UTF-8 for international trials), database schemas that enforce data type constraints, display configurations that render data accurately across different browsers and devices, and print and export functions that produce faithful reproductions of electronic records.

Contemporaneous: Data must be recorded at the time it is generated. IT infrastructure supports contemporaneity through accurate time synchronization across all servers and client devices, timestamp validation that flags entries recorded significantly after the associated event, and offline data capture systems that record the local device time of entry separately from the server synchronization time. Time zone handling is particularly critical for global trials where sites span 12+ hours of difference.

Original: The first recording of data is the original record, and the system must preserve it. Database architecture must maintain the original entry alongside any subsequent modifications, with the audit trail providing a complete history. Infrastructure must prevent true deletion of original records; instead, records should be "soft deleted" or marked inactive while remaining accessible for audit purposes.

Accurate: Data must be free from errors and conform to the protocol. IT infrastructure supports accuracy through real-time edit checks and validation rules executed at the application and database layers, referential integrity constraints in the database schema, and automated range checks, consistency checks, and cross-form validations that fire at data entry time.

Complete, Consistent, Enduring, Available: The "plus" principles require that all data be present without unexplained gaps, that the same data is not recorded differently across systems, that records are maintained throughout their required retention period (often 15-25 years for clinical trials), and that data remains accessible for review throughout the retention period. IT infrastructure must address long-term storage with media migration plans, format preservation strategies, and disaster recovery capabilities that promise data availability across decades, not just years.

Integration Requirements: Connecting CDMS to the Clinical Ecosystem

A clinical data management system does not operate in isolation. Modern clinical trials generate data from multiple sources that must flow into and out of the CDMS reliably, accurately, and with full traceability. IT teams must architect integration infrastructure that handles diverse data formats, protocols, and timing requirements.

HL7 and FHIR for Laboratory Data

Central and local laboratory results represent the highest-volume data feed into most CDMS platforms. Laboratory data typically flows via HL7 v2 messages (ORU/OBX segments) from laboratory information systems, with increasing adoption of HL7 FHIR (Fast Healthcare Interoperability Resources) for newer integrations. IT infrastructure must include an integration engine (Mirth Connect, Rhapsody, or similar) that receives lab data feeds, transforms them to the CDMS import format, validates results against expected ranges and units, and loads them into the correct patient visit within the trial database. The integration must handle re-transmissions, amended results, and results that arrive out of chronological order. A failed lab data integration in a large trial can mean thousands of manual data entry tasks for site coordinators, so redundancy and monitoring are essential.

Medical Imaging Systems

Trials involving imaging endpoints (oncology response assessment, cardiac function measurement, neurological imaging) require integration between the CDMS and medical imaging systems. DICOM (Digital Imaging and Communications in Medicine) is the standard protocol, and the IT infrastructure must support DICOM routing from clinical sites to central imaging repositories, integration between imaging assessment results and the CDMS database, and sufficient network bandwidth for large imaging files (a single CT scan can exceed 500 MB, and PET/CT studies can exceed 2 GB). Imaging data often flows through an independent imaging CRO before results reach the CDMS, requiring secure file transfer infrastructure (SFTP or HTTPS with mutual TLS authentication) between organizations.

IWRS/IRT Systems

Interactive Web/Voice Response Systems (IWRS/IRT) manage randomization and drug supply in clinical trials. The CDMS must integrate with the IRT system to receive treatment assignment data and reconcile drug accountability records. This integration is particularly sensitive because errors can result in patients receiving incorrect treatment assignments or sites running out of study medication. IT infrastructure must support real-time or near-real-time bidirectional data exchange between the CDMS and IRT system, with automated reconciliation checks and alerting when discrepancies are detected.

Safety Databases and Pharmacovigilance

Serious adverse events reported in the CDMS must flow to the sponsor's safety database (commonly Oracle Argus or Veeva Vault Safety) for regulatory reporting. This integration requires E2B(R3) formatted data exchange, typically via secure web services or file-based transfer with acknowledgment. The IT infrastructure must provide reliable, monitored message queuing to handle the asynchronous nature of safety data exchange, and must include alerting for failed transmissions because safety reporting timelines are measured in calendar days (15 days for serious unexpected adverse reactions under FDA regulations, 7 days for fatal or life-threatening events).

Validation: Computer System Validation for IT Infrastructure

Every IT system that supports clinical data management must undergo computer system validation (CSV) before it is used in a regulated trial. CSV provides documented evidence that a system consistently performs according to predetermined specifications and quality attributes. For IT infrastructure, this means validating not just the CDMS application but also the servers, databases, networks, backup systems, and security controls that support it.

The V-Model and IQ/OQ/PQ

Infrastructure validation follows the V-model lifecycle, with qualification activities at three levels. Installation Qualification (IQ) verifies that infrastructure components are installed according to specifications: correct operating system versions, database software versions, network configurations, storage allocations, and security patches. IQ produces documented evidence that the infrastructure matches the approved design. Operational Qualification (OQ) verifies that infrastructure components operate correctly across their anticipated operating ranges: database performance under load, backup completion within defined windows, failover behavior when a primary server fails, network throughput under concurrent user loads, and access control enforcement under various scenarios. Performance Qualification (PQ) verifies that the complete integrated infrastructure performs as expected under real-world conditions: end-to-end data flow from site entry through database storage and audit trail generation, integration data processing under production volumes, and system behavior during peak usage periods.

Validation Documentation

IT infrastructure validation generates substantial documentation that must be maintained throughout the system lifecycle. Required documents include a validation plan defining scope, approach, and acceptance criteria; a requirements specification tracing infrastructure requirements to regulatory requirements; design specifications for server architecture, network topology, database configuration, and security controls; IQ/OQ/PQ protocols with test scripts and expected results; executed test evidence with screenshots, log excerpts, and tester signatures; a traceability matrix linking requirements to test cases to test results; a validation summary report confirming that all acceptance criteria were met; and deviation reports for any test failures with documented resolution and impact assessment. This documentation is what inspectors review during FDA audits. A well-maintained validation package demonstrates that the organization takes infrastructure quality seriously and provides evidence that systems were qualified before use.

Change Control

After initial validation, any change to the IT infrastructure must go through a formal change control process. This includes server patches and updates, database configuration changes, network modifications, storage expansions, security policy updates, and even firmware updates on infrastructure hardware. Each change must be assessed for its impact on the validated state of the system, and regression testing must be performed proportional to the risk of the change. An uncontrolled change to a validated system invalidates the validation and creates a regulatory finding. IT teams accustomed to agile patching cycles must adapt their processes for regulated environments where every infrastructure change requires documentation, approval, testing, and closure before implementation.

Security Architecture for Clinical Data Systems

Clinical trial data includes protected health information (PHI) subject to HIPAA, proprietary research data representing billions of dollars in R&D investment, and regulatory submission data whose integrity must be beyond question. The security architecture for clinical data management systems must address all three categories simultaneously.

HIPAA Compliance

Any clinical data management system that processes data from U.S. clinical sites handles PHI and must comply with the HIPAA Security Rule. IT infrastructure requirements include encryption of PHI at rest (AES-256 for database encryption, full-disk encryption for servers) and in transit (TLS 1.2 or higher for all network communications), access controls that enforce minimum necessary access to PHI, audit logging of all access to records containing PHI, and workforce training on PHI handling procedures. Organizations running clinical trials must also execute Business Associate Agreements (BAAs) with cloud CDMS vendors and any third parties that access or process trial data containing PHI. Petronella's HIPAA compliance services help organizations implement and maintain the technical safeguards required for clinical data environments.

Encryption Strategy

A defense-in-depth encryption strategy for clinical data management includes transparent data encryption (TDE) for the database, protecting data at rest without requiring application changes; column-level encryption for particularly sensitive fields (patient identifiers, genetic data) providing an additional layer beyond TDE; TLS 1.3 for all client-server and server-server communications; VPN or private connectivity for on-premise to cloud data transfers; encrypted backup media with key management separate from the backup infrastructure; and hardware security modules (HSMs) for cryptographic key storage in high-security environments. Key management is the most complex aspect of clinical data encryption. Keys must be rotated periodically, backed up securely, and managed across the full data retention period, which may span 25 years or more for clinical trial records.

Access Control Architecture

Clinical data management requires a multi-layered access control architecture. Network layer controls restrict which networks and IP ranges can reach the CDMS infrastructure. Application layer controls enforce role-based access within the CDMS, mapped to clinical trial roles and study-specific permissions. Database layer controls restrict direct database access to authorized DBAs and prevent application users from bypassing the application to access data directly. Operating system controls harden servers against unauthorized access and restrict administrative privileges. Physical controls protect on-premise infrastructure with locked server rooms, badge access, and visitor logging. Each layer is independently auditable, and the combination provides defense-in-depth that satisfies both cybersecurity best practices and regulatory requirements.

Backup Strategy and Recovery Point Objectives

Clinical trial data is irreplaceable. If a trial enrolls 3,000 patients across 200 sites over three years, losing even a day's worth of data can compromise the statistical analysis plan and delay regulatory submission. The backup strategy for a CDMS must target a recovery point objective (RPO) as close to zero as technically feasible. This requires continuous database replication to a geographically separate secondary site (synchronous replication for RPO of zero, asynchronous for RPO of seconds to minutes), transaction log shipping with frequent intervals (every 5-15 minutes at minimum), daily full backups with automated verification through restore testing, weekly backup integrity verification by restoring to a validation environment and confirming data completeness, and long-term backup retention aligned with regulatory record retention requirements (minimum 2 years after drug approval or investigation conclusion, often 15-25 years in practice). Recovery time objective (RTO) should target 4 hours or less for production systems, with the ability to failover to the secondary site within minutes for the database tier. Organizations that treat backup and disaster recovery as an afterthought in clinical data management are accepting risk that no regulatory agency or sponsor would approve if they understood it.

Building a CDMS Infrastructure Roadmap

Deploying or upgrading IT infrastructure for a clinical data management system is a multi-phase effort that requires coordination between IT, clinical operations, quality assurance, and regulatory affairs. A structured roadmap prevents the common failure mode where infrastructure decisions are made reactively as problems arise during active trials.

Phase 1: Requirements and Gap Analysis. Document the regulatory requirements (21 CFR Part 11, Annex 11, HIPAA, ICH E6 GCP), the CDMS platform requirements, the integration requirements for external systems, and the organization's data volume and user concurrency projections. Compare these requirements against the current infrastructure to identify gaps. This phase typically takes 4-6 weeks and should involve quality assurance and regulatory stakeholders, not just IT.

Phase 2: Architecture Design. Develop the infrastructure architecture including server specifications, network topology, database design, security controls, backup strategy, and disaster recovery plan. Produce design specifications detailed enough to support IQ/OQ/PQ validation. Have the architecture reviewed by both IT security and quality assurance before proceeding. This phase takes 4-8 weeks depending on complexity.

Phase 3: Build and IQ. Procure and configure infrastructure components according to the approved design. Execute Installation Qualification to verify that everything is installed correctly. Document any deviations from the design and assess their impact. This phase takes 4-6 weeks for on-premise deployments, 2-4 weeks for cloud deployments.

Phase 4: OQ/PQ and Go-Live. Execute Operational and Performance Qualification testing. Load realistic data volumes, simulate peak user concurrency, test failover and recovery procedures, and verify all integration data flows end-to-end. Remediate any findings, update documentation, and produce the validation summary report. Obtain quality assurance approval for production use. This phase takes 4-8 weeks and should not be compressed because inadequate testing creates risk that surfaces during active trials when the stakes are highest.

Phase 5: Ongoing Operations. Establish monitoring, alerting, change control, periodic access reviews, backup verification, and disaster recovery testing procedures. Schedule annual requalification activities. Maintain the validation package as a living document that reflects the current state of the infrastructure. Clinical data management is a long-term commitment, and the infrastructure must be actively managed for the full lifecycle of the trials it supports.

Key Takeaways

• A clinical data management system requires IT infrastructure that meets regulatory standards far beyond typical enterprise requirements, including 21 CFR Part 11, HIPAA, and ALCOA+ data integrity principles
• Major CDMS platforms (Medidata Rave, Oracle Clinical, Veeva Vault CDMS, OpenClinica, REDCap) each have distinct infrastructure requirements ranging from full cloud-hosted to on-premise deployments requiring dedicated database administration
• EDC system infrastructure must handle multi-site global trials with reliable network connectivity, mobile data capture, offline synchronization, and peak usage capacity planning
• 21 CFR Part 11 compliance requires specific IT controls for electronic signatures, immutable audit trails, and role-based access controls that cannot be bypassed at any system layer
• ALCOA+ data integrity principles translate directly to infrastructure requirements for time synchronization, audit logging, data preservation, and long-term storage spanning decades
• Integration with clinical systems (labs via HL7/FHIR, imaging via DICOM, IRT for randomization, safety databases via E2B) requires dedicated middleware, monitoring, and redundancy
• Computer system validation (CSV) with IQ/OQ/PQ is mandatory for all infrastructure supporting clinical data, and every subsequent change requires formal change control
• Security architecture must address HIPAA compliance, defense-in-depth encryption, multi-layered access controls, and backup strategies targeting near-zero RPO for irreplaceable trial data

The IT infrastructure behind a clinical data management system is not a commodity service that any general IT team can provide out of the box. It requires specialized knowledge of regulatory requirements, validation methodologies, and the unique operational demands of clinical research. Organizations that build this infrastructure correctly from the start protect their trials, their patients, and their regulatory submissions. Those that treat it as an afterthought spend more on remediation than they would have spent on doing it right the first time.

If your organization is deploying a new CDMS, migrating from a legacy platform, or preparing for an FDA inspection of your clinical data infrastructure, contact Petronella Technology Group to discuss how our managed IT services and compliance expertise can support your clinical data management operations. Call 919-348-4912 to start the conversation.